Level III dissection in locally advanced breast cancer following neoadjuvant chemotherapy: a retrospective study.
CONCLUSION: Level III positivity rate is high and so cannot be avoided in locally advanced breast cancer following neoadjuvant chemotherapy. None of the preoperative factors predict for level III positivity. Level III positivity in cT3N1 and cT2N2 is low and these subgroups require further studies.
PMID: 31755729 [PubMed - as supplied by publisher]
Source: Annals of the Royal College of Surgeons of England - Category: Surgery Authors: Bhargavan RV, Mirza A, Cherian K, Krishna J, Augustine P Tags: Ann R Coll Surg Engl Source Type: research
More News: Breast Cancer | Breast Surgery | Cancer | Cancer & Oncology | Chemotherapy | India Health | Men | Menopause | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Royal College of Surgeons | Study | Surgery